OpenAI's new AI model GPT-Rosalind introduced, major breakthrough in biology research

OpenAI has taken a major step in the life sciences sector by introducing a new AI model, “GPT-Rosalind,” which will help in the field of scientific research and biology.

The model is named after British scientist Rosalind Franklin and is specifically designed to accelerate research in fields such as biochemistry, drug discovery, and disease diagnosis.

According to the company, the model will guide researchers through key steps such as evidence analysis, hypothesis generation, and experimental design, which will speed up the early stages of research.

Through this, scientists will be able to access various databases, read cutting-edge research papers, and also get suggestions for new experiments.

GPT-Rosalind has been made available to limited users through ChatGPT, Codex, and API as a research preview, while a new life sciences plugin is also being introduced that will connect to more than 50 scientific tools.

OpenAI is working with various institutions such as Moderna and Thermo Fisher Scientific to use this model in practical research.

According to experts, this innovative model can significantly accelerate the process of drug development and scientific discovery, which is expected to lead to major changes in the healthcare sector in the future.